Incident Cognitive Impairment in Nonobese Versus Obese Adults Aged 50 Years or Older With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Propensity Score-Matched Cohort Study

More on Alzheimer's disease

• COVID-19 tied to higher dementia risk in older adults with diabetes

  Frontiers in Aging Neuroscience · 4 Oct 2026

• GLP-1 agonists linked to lower dementia risk after COVID-19

  Drug Design, Development and Therapy · 5 Oct 2026

  

• Statins cut Alzheimer's risk but raise other dementia risks

  Journal of Alzheimer's Disease Reports · 4 Oct 2026

  

• SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs

  Diabetes & Vascular Disease Research · 4 Oct 2026